The top pharmaceutical companies by R&D expenditure
Pharmaceutical Technology
MAY 2, 2024
From Merck & Co to Sanofi, Pharmaceutical Technology lists the leading pharmaceutical companies spending the most on R&D in 2023.
Pharmaceutical Companies Related Topics 
Biologics contract manufacturing: A comprehensive guide for pharmaceutical companies
pharmaphorum
JULY 29, 2024
This comprehensive guide provides pharmaceutical companies with valuable insights into biologics contract manufacturing, including the role of CDMOs and key considerations for successful partnerships.
Join 18,000+
Insiders
Sign Up for our Newsletter
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Trending Sources
Can forecasting help identify market opportunities for pharmaceutical companies?
pharmaphorum
JUNE 19, 2023
Can forecasting help identify market opportunities for pharmaceutical companies? Mike.Hammerton Mon, 19/06/2023 - 08:00 Bookmark this
Patients Often Lose in the Battle Between Pharmaceutical Companies and PBMs
Drug Topics
JULY 18, 2023
Over the last 5 years, both PBMs and drug manufacturers have implemented restrictions that raise patients’ cost burden for specialty medications.
STAT+: A new list ranks large pharmaceutical companies by research and development
STAT
MAY 4, 2023
If you want a large pharmaceutical company to invent a new drug, your best bet is probably AstraZeneca. That’s the message from the 12th edition of the Pharmaceutical Innovation and Invention Index, produced by the consultancy Idea Pharma, which was released Thursday at the STAT Breakthrough Summit.
Leading patient adherence pharmaceutical companies
Pharmaceutical Technology
SEPTEMBER 7, 2022
Discover the leading patient adherence pharmaceutical companies. Pharmaceutical Technology has listed the top patient adherence pharmaceutical companies based on our intel, insights and decades-long expertise in the sector. Patient adherence.
Innoviva enters agreement to acquire La Jolla Pharmaceutical Company
Pharmaceutical Technology
JULY 11, 2022
Innoviva has signed a definitive merger agreement for the acquisition of all of the outstanding shares of La Jolla Pharmaceutical Company for $6.23 The post Innoviva enters agreement to acquire La Jolla Pharmaceutical Company appeared first on Pharmaceutical Technology.
STAT+: As pharmaceutical companies bemoan Medicare’s drug negotiations, hospitals and doctors stay mum
STAT
AUGUST 31, 2023
The pharmaceutical industry has been up in arms over Medicare’s first list of 10 prescription drugs that will be subject to negotiations. But other major parts of the health care industry — hospitals, doctors, and other providers — have refrained from either lending support or criticizing the government’s process.
U.S. Pharmaceutical company improved quality of overall documentation saving time and filing delays
Impact Pharmaceutical Services
SEPTEMBER 20, 2023
Challenge Syner-G was contracted by a US Pharmaceutical Company to help improve the quality of submission documentation generated during the manufacture of a Drug Substance intended for Phase II trials. Pharmaceutical company improved quality of overall documentation saving time and filing delays appeared first on SYNER-G.
The Importance of the Medical Affairs Function in Pharmaceutical Companies
PharmExec
NOVEMBER 20, 2023
Study emphasizes role in bridging research and development and commercial/marketing functions.
Process improvements and in-person monitoring help U.S. pharmaceutical company achieve on time for Phase III clinical trials
Impact Pharmaceutical Services
SEPTEMBER 20, 2023
pharmaceutical company to oversee a 6 month, DS manufacturing as Person-In- Plant (PIP) and assist with preparation of associated submission documents related to Phase III clinical trial batches. pharmaceutical company achieve on time for Phase III clinical trials appeared first on SYNER-G.
FDA Approves Aprocitentan For Treatment of Uncontrolled High Blood Pressure
Drug Topics
MARCH 20, 2024
Aprocitentan (TRYVIO) from pharmaceutical company Idorsia demonstrated statistically significant and clinically meaningful reductions in blood pressure in combination with other antihypertensive therapies.
The Importance of the Medical Affairs Function in Pharmaceutical Companies
Pharmaceutical Commerce
NOVEMBER 20, 2023
Study emphasizes role in bridging research and development and commercial/marketing functions.
A decade of cancer immunotherapy: Keytruda, Opdivo and the drugs that changed oncology
PharmaVoice
SEPTEMBER 10, 2024
But the steady expansion of their use has slowed and, despite much trying, pharmaceutical companies have largely failed to top the drugs’ successes. Over the past 10 years, PD1-blocking medicines have transformed cancer care.
Why do pharmaceutical companies offer a strong value proposition?
Berkeley Pharma Tech
APRIL 15, 2022
As of 2022, working within the pharmaceutical sector is one of the best ways to create a meaningful impact on society. Research, development, manufacturing, and prescribing medications are an integral part of the mission of the pharmaceutical industry which is to ultimately enhance the lives of many.
Certa’s CEO Jag Lamba on enhancing pharma supply chain traceability and compliance
Outsourcing Pharma
AUGUST 14, 2024
In an increasingly complex regulatory landscape, pharmaceutical companies face significant challenges in maintaining transparency and accountability across their global supply chains.
You’re trusted less than a waiter and more than a pilot, but why?
pharmaphorum
AUGUST 8, 2024
Discover why pharmaceutical companies are trusted less than a waiter, but more than a pilot, and explore the role of Patient Advocacy Groups (PAGs) in shaping trust in the pharmaceutical industry.
Opinion: How Pfizer ended up passing on my GLP-1 work back in the early ’90s
STAT
SEPTEMBER 9, 2024
Rather, I think the story offers valuable lessons on drug development for pharmaceutical companies, researchers, and the general public alike. To be clear, I’m not writing this to claim credit for discovery or development of GLP-1s or anything like that. Read the rest…
AstraZeneca withdraws Covid-19 vaccine worldwide, citing surplus of newer vaccines
The Guardian - Pharmaceutical Industry
MAY 7, 2024
Pharmaceutical company says newer shots led to decline in demand for AstraZeneca vaccine, which is no longer being manufactured or supplied AstraZeneca has begun the worldwide withdrawal of its Covid-19 vaccine due to a “surplus of available updated vaccines” that target new variants of the virus.
Vaccines 
111
111 
STAT+: Pharma is still struggling to widen access to medicines — and reach patients — in low- and middle-income countries
STAT
SEPTEMBER 10, 2024
Amid calls to expand access to medicines in low- and middle-income countries, a new analysis finds that most of the world’s 20 largest pharmaceutical companies have taken steps to reach patients, but many efforts are yielding decidedly mixed results.
Pharma companies must prioritize patient reach, report says
Outsourcing Pharma
SEPTEMBER 10, 2024
Pharmaceutical companies are under increasing pressure to ensure that essential healthcare products are accessible to all, regardless of socioeconomic status or location.
AstraZeneca Caps Out-of-Pocket Inhaler Costs at $35 Per Month
Drug Topics
MARCH 18, 2024
AstraZeneca is the second pharmaceutical company to cap out-of-pocket costs for eligible patients.
How early utilisation of AI can de-risk and accelerate clinical development
Outsourcing Pharma
SEPTEMBER 12, 2024
Recent investments by major pharmaceutical companies signal a growing confidence in artificial intelligenceâs (AI's) potential to transform drug development.
How biometrics applications are contributing to clinical trial diversity
pharmaphorum
JULY 31, 2024
Ensuring equitable access to medications remains a fundamental commitment for many pharmaceutical companies to their customers, patients, and stakeholders. However, there has been a discernible shift recently in the timing of access discussions.
STAT+: FDA scolds AbbVie over ‘misleading’ TV ad for a migraine pill featuring Serena Williams
STAT
SEPTEMBER 11, 2024
Food and Drug Administration has scolded AbbVie for making false and misleading claims about a TV ad about a migraine pill that features Serena Williams, the third time this year the agency has taken a major pharmaceutical company to task for its marketing. The agency is upset with Abbvie for a couple of reasons.
FDA 116
116 
Watch: How drug patents pave the way to profit
STAT
AUGUST 8, 2024
Discovering a new drug is a big win for a pharmaceutical company, but selling it for lots of money with no competition? This is Part 3 of “Behind the Counter,” an in-depth video series demystifying the complex world of patents and drug pricing. The cherry on top. Read the rest…
Engaging Communities through High-Impact Healthcare Sponsorships in the Pharmaceutical Industry
Pharma Marketing Network
JULY 19, 2023
Sponsorships can be a powerful tool for pharmaceutical companies to engage with communities and make a positive impact on health and wellness. When done right, sponsorships can help pharmaceutical companies connect with their target audience, build relationships with key stakeholders, and promote their brand in a meaningful way.
What can pharma companies do to quicken the pace of digital disruption?
pharmaphorum
JUNE 10, 2024
Discover how pharmaceutical companies can leverage digital technologies to accelerate innovation and disrupt the industry. Learn about regulatory considerations and engagement with healthcare professionals (HCPs) for successful digital transformation.
Sunshine transparency reporting for emerging pharma: Simplify, streamline, and secure
pharmaphorum
APRIL 10, 2024
Discover how Sunshine transparency reporting can be simplified, streamlined, and secured for emerging pharmaceutical companies with a focus on Healthcare Professionals (HCP) and Healthcare Organisations (HCO).
Pain is reduced by almost half with cannabis-based medicines – report finds
Outsourcing Pharma
MARCH 11, 2024
On March 7, Celadon Pharmaceuticals plc, a leading UK-based pharmaceutical company specializing in cannabis-based medicines, unveiled promising findings from an early economic analysis of its chronic pain clinical trial, dubbed CANPAIN.
Listen: Biotech layoffs, founder-focused VC, & a big pharma exit
STAT
JULY 11, 2024
Why are pharmaceutical companies cutting more staff than cash-strapped biotechs? And who will Pfizer scout out as its next science chief? STAT’s West Coast biotech reporter Jonathan Wosen joins “The Readout LOUD” to discuss what’s driving workforce cuts. Read the rest…
Harm Reduction Therapeutics Begins Shipping OTC Naloxone Nasal Spray
Drug Topics
DECEMBER 21, 2023
The nonprofit pharmaceutical company plans to begin fulfilling orders for RiVive more broadly in early 2023 and will make it available across the US for free of charge or at a low breakeven cost.
Opinion: The Pandemic Treaty will succeed only with investment to build strong health systems
STAT
MAY 31, 2024
The vested interests of pharmaceutical companies, lobbying groups, and conservative British broadcaster Nigel Farage bleating about “defending sovereignty” are threatening to derail the treaty process entirely. The treaty has been beset by delay and misinformation.
Why is pharma going gaga for radiopharmaceuticals?
pharmaphorum
FEBRUARY 27, 2024
Pharmaceutical companies are increasingly focusing on radiopharmaceuticals due to their potential in oncology and therapeutic applications. Learn more about why the industry is excited about radioisotopes in this article.
Creating Synergy: Aligning Brand Values with High-Impact Healthcare Sponsorships in the Pharmaceutical Industry
Pharma Marketing Network
JULY 19, 2023
But in order to be truly effective, sponsorships must be aligned with a company’s brand values. For pharmaceutical companies, this means aligning sponsorships with causes that are related to health and wellness. In 2020, the company committed to investing $5 billion in research and development over the next five years.
What pharma stands to gain from technological innovation
pharmaphorum
APRIL 22, 2024
Pharmaceutical companies stand to gain significant benefits from technological innovation in the form of improved data analytics, streamlined healthcare processes, and enhanced patient outcomes. Explore the potential advantages for the pharma industry.
Beyond the Pill: Creating Value with Patient-Centric Pharmaceutical Marketing
Pharma Marketing Network
JULY 12, 2023
In order to succeed in this challenging environment, pharmaceutical companies need to adopt a patient-centric approach to marketing. Patient-centric pharmaceutical marketing is based on the understanding that patients are more than just consumers of drugs. It is also about changing the mindset of pharmaceutical companies.
Is the flu shot market a slam dunk for mRNA vaccines? Experts aren’t so sure
STAT
DECEMBER 5, 2023
And pharmaceutical companies that learned of the vaccine-making power of the messenger RNA platform during the Covid-19 pandemic need new markets for their technology. Here are two things that are true. The world needs more effective flu vaccines. Read the rest…
Vaccines 145
145 
LSX World Congress – Day Two
pharmaphorum
SEPTEMBER 12, 2024
Join us for Day Two of LSX World Congress featuring presentations from top pharmaceutical companies like AstraZeneca, Takeda, Merck, Roche, Johnson & Johnson, Bayer and more. Get insights into the latest trends and innovations in the life sciences industry.
Novavax: Creating tomorrow’s vaccines today
pharmaphorum
JANUARY 10, 2024
Novavax is a leading pharmaceutical company dedicated to creating protein-based vaccines for diseases like COVID-19 and malaria. Learn more about their innovative vaccine development process and their commitment to creating a healthier future.
Vaccines 124
124 
Opinion: The FDA should withdraw approval of more than 400 tainted medicines
STAT
AUGUST 12, 2024
Instead, it has allowed these drugs to continue to be prescribed and distributed for at least a year as the pharmaceutical companies retest them for equivalency to the original brand-name drugs.
FDA 140
140 
How the Life Sciences Innovative Manufacturing Fund can boost funding for pharma
pharmaphorum
AUGUST 30, 2024
Discover how the Life Sciences Innovative Manufacturing Fund can help boost funding for pharmaceutical companies. Learn how this fund can support innovation and growth in the life sciences sector.
Johnson & Johnson accuses former employee of taking thousands of files to new role at Pfizer
Fierce Pharma
MARCH 20, 2024
As two of the world’s largest pharmaceutical companies, Johnson & Johnson and Pfizer have long been rivals in various therapeutic areas. | The company is accusing former employee Andrew Brackbill of downloading thousands of confidential strategy-related files before leaving for rival Pfizer.
Artificial Intelligence is Changing the Face of Pharmacovigilance
Pharmacy Times
OCTOBER 17, 2022
Pharmaceutical companies are looking into AI as the new method to not only reduce research and development costs, but also prevent costly errors.
Let's personalize your content